Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer
This randomized phase II trial studies the side effects and how well postoperative intensity
modulated radiation therapy works after surgery in treating patients with urothelial bladder
cancer. Radiation therapy uses high energy x-rays to kill tumour cells left behind in the
pelvis after surgery. It is not yet known whether surgery followed by radiation therapy is more
effective than surgery alone in treating patients with urothelial bladder cancer.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society